KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jul 16, 2026 - 3:59PM >>  ABB India 7667.9  [ 6.45% ]  ACC 1374.6  [ -0.58% ]  Ambuja Cements 433.3  [ -0.44% ]  Asian Paints 2667.5  [ -0.09% ]  Axis Bank 1304.7  [ -0.61% ]  Bajaj Auto 10301  [ -0.17% ]  Bank of Baroda 248.3  [ 0.04% ]  Bharti Airtel 1923  [ 0.29% ]  Bharat Heavy 435.4  [ 4.13% ]  Bharat Petroleum 312  [ 0.71% ]  Britannia Industries 5302  [ -0.31% ]  Cipla 1428  [ -0.69% ]  Coal India 427.4  [ -0.02% ]  Colgate Palm 1997  [ -0.69% ]  Dabur India 429.45  [ -0.35% ]  DLF 647.6  [ -1.52% ]  Dr. Reddy's Lab. 1223.9  [ -0.48% ]  GAIL (India) 171.65  [ -0.84% ]  Grasim Industries 3062.7  [ -0.70% ]  HCL Technologies 1188.05  [ 1.73% ]  HDFC Bank 808.3  [ -0.86% ]  Hero MotoCorp 4887.75  [ 0.22% ]  Hindustan Unilever 2098  [ -0.21% ]  Hindalco Industries 959.65  [ 0.43% ]  ICICI Bank 1418.2  [ 0.17% ]  Indian Hotels Co. 733.15  [ -1.34% ]  IndusInd Bank 1012.45  [ 0.34% ]  Infosys 1081.05  [ 0.43% ]  ITC 279.35  [ 1.05% ]  Jindal Steel 1027.55  [ -1.48% ]  Kotak Mahindra Bank 377.15  [ -0.33% ]  L&T 3775.75  [ -0.22% ]  Lupin 2505  [ 0.53% ]  Mahi. & Mahi 3120.45  [ 1.20% ]  Maruti Suzuki India 13773.1  [ 1.42% ]  MTNL 28.74  [ 1.38% ]  Nestle India 1425.8  [ 0.01% ]  NIIT 98.9  [ 3.07% ]  NMDC 84.07  [ -0.99% ]  NTPC 342.5  [ -0.54% ]  ONGC 246.9  [ -0.04% ]  Punj. NationlBak 105.2  [ -0.47% ]  Power Grid Corpn. 280.8  [ 0.04% ]  Reliance Industries 1293  [ -0.19% ]  SBI 1031.35  [ 0.13% ]  Vedanta 257.9  [ -1.04% ]  Shipping Corpn. 289  [ 0.42% ]  Sun Pharmaceutical 1951.3  [ -0.06% ]  Tata Chemicals 694  [ -0.62% ]  Tata Consumer 1087  [ 0.14% ]  Tata Motors Passenge 331.8  [ -0.36% ]  Tata Steel 185.5  [ 0.13% ]  Tata Power Co. 377  [ -0.98% ]  Tata Consult. Serv. 2201.8  [ 0.59% ]  Tech Mahindra 1515.85  [ 1.15% ]  UltraTech Cement 11768.3  [ -0.36% ]  United Spirits 1383.05  [ 0.72% ]  Wipro 177.8  [ 1.83% ]  Zee Entertainment 105.85  [ 3.88% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AAREY DRUGS & PHARMACEUTICALS LTD.

16 July 2026 | 03:15

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE198H01019 BSE Code / NSE Code 524412 / AAREYDRUGS Book Value (Rs.) 53.02 Face Value 10.00
Bookclosure 30/09/2024 52Week High 100 EPS 1.40 P/E 54.62
Market Cap. 216.68 Cr. 52Week Low 50 P/BV / Div Yield (%) 1.44 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd.

The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate.

2008

-Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008.

2012

-Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1

-Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5

2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.